|
⚲
|
| Keyboard |
| Raab G Kirk
✚
|
|
|---|---|
| CIK # | 0001210530 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001210530] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Transcept Pharmaceuticals Inc | |
| Raab G Kirk |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Transcept Pharmaceuticals Inc TSPT
Stock option (right to buy) · derivative
|
2014-10-30 | Disposed to issuer | 3,750 | ||
|
Transcept Pharmaceuticals Inc TSPT
Stock option (right to buy) · derivative
|
2014-10-30 | Disposed to issuer | 1,458 | ||
|
Transcept Pharmaceuticals Inc TSPT
Stock option (right to buy) · derivative
|
2014-10-30 | Disposed to issuer | 3,166 | ||
|
Transcept Pharmaceuticals Inc TSPT
Stock option (right to buy) · derivative
|
2014-10-30 | Disposed to issuer | 5,208 | ||
|
Transcept Pharmaceuticals Inc TSPT
Stock option (right to buy) · derivative
|
2014-10-30 | Disposed to issuer | 1,666 | ||
|
Transcept Pharmaceuticals Inc TSPT
Stock option (right to buy) · derivative
|
2014-10-30 | Disposed to issuer | 416 | ||
|
Transcept Pharmaceuticals Inc TSPT
Common Stock Option (right to buy) · derivative
|
2013-01-07 | Grant | 62,500 | $0.00 | |
|
Transcept Pharmaceuticals Inc TSPT
Stock Option (right to buy) · derivative
|
2012-02-01 | Grant | 45,000 | $0.00 |